Pharma Holdings
Oslo, Norway· Est.
By rethinking treatments against respiratory viral infections, Pharma Holdings is championing intranasal virucidal products that will reduce the risk of severe infections for patients globally.
Private Company
Funding information not available
About
By rethinking treatments against respiratory viral infections, Pharma Holdings is championing intranasal virucidal products that will reduce the risk of severe infections for patients globally.
Drug Delivery